UNSPSC 51102832: Chloramphenicol/hydrocortisone/polymyxin b

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP350. This VA Drug Class (OP350) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL OPHTHALMIC.

UNSPSC 51102832 Chloramphenicol/hydrocortisone/polymyxin b is a Commodity code that nominally identifies a specific antibiotic-steroid ophthalmic combination product, but recent state and local solicitations tagged under this code show no active buying of that formulation. Instead, the tagged opportunities reflect pharmaceutical procurement more broadly — including antibiotic tablets, naloxone, and drug deactivation systems — suggesting the code is either misapplied in state procurement systems or used as a catch-all for pharmaceutical inventory purchases that do not match the code's precise drug specification. State and local health departments and county public health authorities are the primary issuing bodies, using cooperative purchasing vehicles and piggyback contracts to consolidate pharmaceutical supply.

The geographic activity documented includes Illinois and Florida. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, valued at $2,999,999.11 over three years, covering Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets through an Invitation for Bid process. Seminole County, Florida issued an IFB (number IFB60459723LAS) posted June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the bid had a July 26, 2023, response deadline, indicating either a data-entry discrepancy or a stale record. Vendors on the Florida procurement must provide unit costs, submit electronically, include shipping and delivery costs in proposals, and meet drug-free workplace and E-Verify compliance requirements.